Metabolic fate of endocannabinoids

Current Neuropharmacology

Volumn 2, Issue 1, 2004, Pages 37-48

  van der Stelt, Mario ^a   Di Marzo, Vincenzo ^a  

^a CNR   (Italy)

Author keywords

2 AG; Anandamide; Cannabinoid; Cyclooxygenase; Fatty acid amide hydrolase; Lipoxygenase; Mono acyl glycerol lipase; Prostamide

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ACYLGLYCEROL LIPASE; AMIDE; ANANDAMIDE; BIMATOPROST; CANNABINOID; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; DOPAMINE 2 RECEPTOR; ESTER; FATTY ACID AMIDASE; FUNCTIONAL GROUP; GLYCEROL; HYDROLASE INHIBITOR; LIPOXYGENASE; N (3 FURYLMETHYL)ARACHIDONAMIDE; N (4 HYDROXY 2 METHYLPHENYL)ARACHIDONAMIDE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; N METHYL DEXTRO ASPARTIC ACID; NEUROTRANSMITTER; O 1624; PRESYNAPTIC RECEPTOR; PRODRUG; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; URB 532; VANILLOID RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANXIETY DISORDER; CELL ACTIVITY; EXTRACELLULAR SPACE; HUMAN; HYDROLYSIS; INTRACELLULAR TRANSPORT; METABOLIC PARAMETERS; MOLECULAR CLONING; NERVE CELL PLASTICITY; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; OXYGENATION; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; WITHDRAWAL SYNDROME;

EID: 2442715648     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570159043476864     Document Type: Review

References (100)

1. Baker, D., Pryce, G., Croxford, J.L.., Brown, P., Pertwee, R.G., Makriyannis, A., Khanolkar, A., Layward, L., Fezza, F., Bisogno, T. and Di Marzo, V. (2001) Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J., 15, 300-302.
2. Basavarajappa, B.S., Saito, M., Cooper, T.B. and Hungund, B.L. (2003) Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons. Eur. J. Pharmacol., 466, 73-83.
3. Beltramo, M., de Fonseca, F.R., Navarro, M., Calignano, A., Gorriti, M.A., Grammatikopoulos, G., Sadile, A.G., Giuffrida, A. and Piomelli, D. (2000) Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor. J. Neurosci., 20, 3401-3407.
4. Beltramo, M., Stella, N., Calignano, A., Lin, S.Y., Makriyannis, A. and Piomelli, D. (1997) Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science, 277, 1094-1097.
5. Berglund, B.A., Boring, D.L. and Howlett, A.C. (1999) Investigation of structural analogs of prostaglandin amides for binding to and activation of CB1 and CB2 cannabinoid receptors in rat brain and human tonsils. Adv. Exp. Med. Biol., 469, 527-533.
6. Bisogno, T., Maccarrone, M., De Petrocellis, L., Jarrahian, A., Finazzi-Agro, A., Hillard, C. and Di Marzo, V. (2001) The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors. Eur. J. Biochem., 268, 1982-1989.
7. Bornheim, L.M., Kim, K.Y., Chen, B. and Correia, M.A. (1993) The effect of cannabidiol on mouse hepatic microsomal cytochrome P450- dependent anandamide metabolism. Biochem. Biophys. Res. Commun., 197, 740-746.
8. Bornheim, L.M., Kim, K.Y., Chen, B. and Correia, M.A. (1995) Microsomal cytochrome P450-mediated liver and brain anandamide metabolism. Biochem. Pharmacol., 50, 677-686.
9. Bracey, M.H., Hanson, M.A., Masuda, K.R., Stevens, R.C. and Cravatt, B.F. (2002) Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science, 298, 1793-1796.
10. Burstein, S.H., Huang, S.M., Petros, T.J., Rossetti, R.G., Walker, J.M. and Zurier, R.B. (2002) Regulation of anandamide tissue levels by N-arachidonylglycine. Biochem. Pharmacol., 64, 1147-1150.
11. Burstein, S.H., Rossetti, R.G., Yagen, B. and Zurier, R.B. (2000) Oxidative metabolism of anandamide. Prostaglandins Other Lipid Mediat., 61, 29-41.
12. Chu, C.J., Huang, S.M., De Petrocellis, L., Bisogno, T., Ewing, S.A., Miller, J.D., Zipkin, R.E., Daddario, N., Appendino, G., Di Marzo, V. and Walker, J.M. (2003) N-oleoyldopamine: A novel endogenous capsaicin-like lipid that produces hyperalgesia. J. Biol. Chem., 4,4.
13. Craib, S.J., Ellington, H.C., Pertwee, R.G. and Ross, R.A. (2001) A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus. Br. J. Pharmacol., 134, 30-37.
14. Cravatt, B.F., Demarest, K., Patricelli, M.P., Bracey, M.H., Giang, D.K., Martin, B.R. and Lichtman, A.H. (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. USA, 98, 9371-9376.
15. Cravatt, B.F., Giang, D.K., Mayfield, S.P., Boger, D.L., Lerner, R.A. and Gilula, N.B. (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature, 384, 83-87.
16. Cravatt, B.F., Prospero-Garcia, O., Siuzdak, G., Gilula, N.B., Henriksen, S.J., Boger, D.L. and Lerner, R.A. (1995) Chemical characterization of a family of brain lipids that induce sleep. Science, 268, 1506-1509.
17. Day, T.A., Rakhshan, F., Deutsch, D.G. and Barker, E.L. (2001) Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide. Mol. Pharmacol., 59, 1369-1375.
18. De Petrocellis, L., Bisogno, T., Davis, J.B., Pertwee, R.G. and Di Marzo, V. (2000) Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett., 483, 52-56.
19. De Petrocellis, L., Bisogno, T., Maccarrone, M., Davis, J.B., Finazzi-Agro, A. and Di Marzo, V. (2001) The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J. Biol. Chem., 276, 12856-12863.
20. Deadwyler, S.A., Hampson, R.E., Bennett, B.A., Edwards, T.A., Mu, J., Pacheco, M.A., Ward, S.J. and Childers, S.R. (1993) Cannabinoids modulate potassium current in cultured hippocampal neurons. Receptors Channels, 1, 121-134.
21. Deadwyler, S.A., Hampson, R.E., Mu, J., Whyte, A. and Childers, S. (1995) Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process. J. Pharmacol. Exp. Ther., 273, 734-743.
22. Del Arco, I., Navarro, M., Bilbao, A., Ferrer, B., Piomelli, D. and Rodriguez De Fonseca, F. (2002) Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404. Eur. J. Pharmacol., 454, 103-104.
23. Desarnaud, F., Cadas, H. and Piomelli, D. (1995) Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. J. Biol. Chem., 270, 6030-6035.
24. Deutsch, D.G. and Chin, S.A. (1993) Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem. Pharmacol., 46, 791-796.
25. Deutsch, D.G., Glaser, S.T., Howell, J.M., Kunz, J.S., Puffenbarger, R.A., Hillard, C.J. and Abumrad, N. (2001) The cellular uptake of anandamide is coupled to its breakdown by fatty- acid amide hydrolase. J. Biol. Chem., 276, 6967-6973.
26. Deutsch, D.G., Ueda, N. and Yamamoto, S. (2002) The fatty acid amide hydrolase (FAAH). Prostaglandins Leukot Essent Fatty Acids, 66, 201-210.
27. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. and Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949.
28. Di Marzo, V., Bisogno, T. and De Petrocellis, L. (2000) Endocannabinoids: new targets for drug development. Curr. Pharm. Des., 6, 1361-1380.
29. Di Marzo, V., Bisogno, T., De Petrocellis, L., Melck, D., Orlando, P., Wagner, J.A. and Kunos, G. (1999) Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur. J. Biochem., 264, 258-267.
30. Di Marzo, V., Bisogno, T., Sugiura, T., Melck, D. and De Petrocellis, L. (1998) The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide. Biochem. J., 331, 15-19.
31. Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.C. and Piomelli, D, (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature, 372, 686-691.
32. Di Marzo, V., Melck, D., Bisogno, T. and De Petrocellis, L. (1998) Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci., 21, 521-528.
33. Dinh, T.P., Carpenter, D., Leslie, F.M., Freund, T.F., Katona, I., Sensi, S.L., Kathuria, 'S. and Piomelli, D. (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. USA, 99, 10819-10824.
34. Edgemond, W.S., Hillard, C.J., Falck, J.R., Kearn, C.S. and Campbell, W.B. (1998) Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation. Mol. Pharmacol., 54, 180-188.
35. Farooqui, A.A., Anderson, D.K., Flynn, C., Bradel, E., Means, E.D. and Horrocks, L.A. (1990) Stimulation of mono- and diacylglycerol lipase activities by bradykinin in neural cultures. Biochem. Biophys. Res. Commun., 166, 1001-1009.
36. Farooqui, A.A., Anderson, D.K. and Horrocks, L.A. (1993) Effect of glutamate and its analogs on diacylglycerol and monoacylglycerol lipase activities of neuron-enriched cultures. Brain Res., 604, 180-184.
37. Fezza, F., Bisogno, T., Minassi, A., Appendino, G., Mechoulam, R. and Di Marzo, V. (2002) Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues. FEBS Lett., 513, 294-298.
38. Fowler, C.J. and Jacobsson, S.O. (2002) Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide-targets for drug development? Prostaglandins Leukot. Essent. Fatty Acids, 66, 193-200.
39. Giang, D.K. and Cravatt, B.F. (1997) Molecular characterization of human and mouse fatty acid amide hydrolases. Proc. Natl. Acad. Sci. USA, 94, 2238-2242.
40. Glaser, S.T., Abumrad, N.A., Fatade, F., Kaczocha, M., Studholme, K.M. and Deutsch, D.G. (2003) Evidence against the presence of an anandamide transporter. Proc. Natl. Acad. Sci. USA, 24, 24.
41. Goparaju, S.K., Ueda, N., Yamaguchi, H. and Yamamoto, S. (1998) Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Lett., 422, 69-73.
42. Gubellini, P., Picconi, B., Bari, M., Battista, N., Calabresi, P., Centonze, D., Bernardi, G., Finazzi-Agro, A. and Maccarrone, M. (2002) Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J. Neurosci., 22, 6900-6907.
43. Hampson, A.J., Hill, W.A., Zan-Phillips, M., Makriyannis, A., Leung, E., Eglen, R.M. and Bornheim, L.M. (1995) Anandamide hydroxylation by brain lipoxygenase: metabolite structures and potencies at the cannabinoid receptor. Biochim. Biophys. Acta., 1259, 173-179.
44. Hanus, L., Abu-Lafi, S., Fride, E., Breuer, A., Vogel, Z., Shalev, D.E., Kustanovich, I. and Mechoulam, R. (2001) 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc. Natl. Acad. Sci. USA, 98, 3662-3665.
45. Hillard, C.J., Edgemond, W.S., Jarrahian, A. and Campbell, W.B. (1997) Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J. Neurochem., 69, 631-638.
46. Hillard, C.J. and Jarrahian, A. (2000) The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. Chem. Phys. Lipids, 108, 123-134.
47. Ho, S.Y., Delgado, L. and Storch, J. (2002) Monoacylglycerol metabolism in human intestinal Caco-2 cells: evidence for metabolic compartmentation and hydrolysis. J. Biol. Chem., 277, 1816-1823.
48. Huang, S.M., Bisogno, T., Petros, T.J., Chang, S.Y., Zavitsanos, P.A., Zipkin, R.E., Sivakumar, R., Coop, A., Maeda, D.Y., De Petrocellis, L., Burstein, S., Di Marzo, V. and Walker, J.M. (2001) Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J. Biol. Chem., 276, 42639-42644.
49. Huang, S.M., Bisogno, T., Trevisani, M., Al-Hayani, A., De Petrocellis, L., Fezza, F., Tognetto, M., Petros, T..J, Krey, J.F., Chu, C.J., Miller, J.D., Davies, S.N., Geppetti, P., Walker, J.M. and Di Marzo, V. (2002) An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. USA, 99, 8400-8405.
50. Hwang, S.W., Cho, H., Kwak, J., Lee, S.Y., Kang, C.J., Jung, J., Cho, S., Min, K.H., Suh, Y.G., Kim, D. and Oh, U. (2000) Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc. Natl. Acad. Sci. USA, 97, 6155-6160.
51. Jarrahian, A., Manna, S., Edgemond, W.S., Campbell, W.B. and Hillard, C.J. (2000) Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter. J. Neurochem., 74, 2597-2606.
52. Kagaya, M., Lamb, J., Robbins, J., Page, C.P. and Spina, D. (2002) Characterization of the anandamide induced depolarization of guinea-pig isolated vagus nerve. Br. J. Pharmacol., 137, 39-48.
53. Karlsson, M., Contreras, J.A., Hellman, U., Tornqvist, H. and Holm, C. (1997) cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J. Biol. Chem., 272, 27218-27223.
54. Kathuria, S., Gaetani, S., Fegley, D., Valino, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., La Rana, G., Calignano, A., Giustino, A., Tattoli, M., Palmery, M., Cuomo, V. and Piomelli, D. (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat. Med., 9, 76-81.
55. Kozak, K.R., Crews, B.C., Morrow, J.D., Wang, L.H., Ma, Y.H., Weinander, R., Jakobsson, P.J. and Marnett, L.J. (2002) Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. J. Biol. Chem., 19, 19.
56. Kozak, K.R., Crews, B.C., Ray, J.L., Tai, H.H., Morrow, J.D. and Marnett, L.J. (2001) Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo. J. Biol. Chem., 276, 36993-36998.
57. Kozak, K.R., Gupta, R.A., Moody, J.S., Ji, C., Boeglin, W.E., DuBois, R.N., Brash, A.R. and Marnett, L.J. (2002) 15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist. J. Biol. Chem., 277, 23278-23286.
58. Kozak, K.R. and Marnett, L.J. (2002) Oxidative metabolism of endocannabinoids. Prostaglandins Leukot. Essent. Fatty Acids, 66, 211-220.
59. Kozak, K.R., Rowlinson, S.W. and Marnett, L.J. (2000) Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. J. Biol. Chem., 275, 33744-33749.
60. Lambert, D.M. and Di Marzo, V. (1999) The palmitoylethanolamide and oleamide enigmas: are these two fatty acid amides cannabimimetic? Curr. Med. Chem., 6, 757-773.
61. Lastres-Becker, I., de Miguel, R., De Petrocellis, L., Makriyannis, A., Di Marzo, V. and Fernandez-Ruiz, J. (2003) Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease. J. Neurochem., 84, 1097-1109.
62. Lopez-Rodriguez, M.L., Viso, A., Ortega-Gutierrez, S., Fowler, C.J., Tiger, G., de Lago, E., Fernandez-Ruiz, J. and Ramos, J.A. (2003) Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase. J. Med. Chem., 46, 1512-1522.
63. Lopez-Rodriguez, M.L., Viso, A., Ortega-Gutierrez, S., Lastres-Becker, I., Gonzalez, S., Fernandez-Ruiz, J. and Ramos J.A. (2001) Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors. J. Med. Chem., 44, 4505-4508.
64. Lutz, B. (2002) Molecular biology of cannabinoid receptors. Prostaglandins Leukot. Essent. Fatty Acids, 66, 123-142.
65. Maccarrone, M., Bari, M., Battista, N. and Finazzi-Agro, A. (2002) Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation. Blood, 1, 1.
66. Maccarrone, M., Bari, M., Lorenzon, T., Bisogno, T., Di Marzo, V. and Finazzi-Agro, A. (2000) Anandamide uptake by human endothelial cells and its regulation by nitric oxide. J. Biol. Chem., 275, 13484-13492.
67. Maccarrone, M., De Petrocellis, L., Bari, M., Fezza, F., Salvati, S., Di Marzo, V. and Finazzi-Agro, A. (2001) Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes. Arch. Biochem. Biophys., 393, 321-328.
68. Maccarrone, M., Valensise, H., Bari, M., Lazzarin, N., Romanini, C. and Finazzi-Agro, A. (2001) Progesterone up-regulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility. J. Immunol., 166, 7183-7189.
69. Maccarrone, M., van der Stelt, M., Rossi, A., Veldink, G.A., Vliegenthart, J.F. and Agro, A.F. (1998) Anandamide hydrolysis by human cells in culture and brain. J. Biol. Chem., 273, 32332-32339.
70. Martin, B.R., Beletskaya, I., Patrick, G., Jefferson, R., Winckler, R., Deutsch, D.G., Di Marzo, V., Dasse, O., Mahadevan, A. and Razdan, R.K. (2000) Cannabinoid properties of methylfluorophosphonate analogs. J. Pharmacol. Exp. Ther., 294, 1209-1218.
71. Mascolo, N., Izzo, A.A., Ligresti, A., Costagliola, A., Pinto, L., Cascio, M.G., Maffia, P., Cecio, A., Capasso, F. and Di Marzo, V. (2002) The endocannabinoid system and the molecular basis of paralytic ileus in mice. FASEB J., 18, 18.
72. Matias, I., Chen, J., De Petrocellis, L., Bisogno, T., Ligresti, A., Fezza, F., Krauss, A.H-P., Shi, L., Protzman, C.E., Li, C., Liang, Y., Nieves, A.L., Kedzie, K.M., Burk, R.M., Di Marzo, V. and Woodward, D. Prostaglandin-ethanolamides (prostamides): In vitro pharmacology and metabolism. (submitted).
73. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C. and Bonner, T.I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561-564.
74. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N.E., Schatz, A.R., Gopher, A., Almog, S., Martin, B.R., Compton, D.R., Pertwee, R.G., Griffin, G., Bayewitch, M., Barg, J. and Vogel, Z. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol., 50, 83-90.
75. Moody, J.S., Kozak, K.R., Ji, C. and Marnett, L.J. (2001) Selective oxygenation of the endocannabinoid 2-arachidonylglycerol by leukocyte-type 12-lipoxygenase. Biochemistry, 40, 861-866.
76. Munro, S., Thomas, K.L. and Abu-Shaar, M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365, 61-65.
77. Ohno-Shosaku, T., Maejima, T. and Kano, M. (2001) Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron, 29, 729-738.
78. Patricelli, M.P. and Cravatt, B.F. (2000) Clarifying the catalytic roles of conserved residues in the amidase signature family. J. Biol. Chem., 275, 19177-19184.
79. Pertwee, R.G. (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther., 74, 129-180.
80. Pinto, L., Izzo, A.A., Cascio, M.G., Bisogno, T., Hospodar-Scott, K., Brown, D.R., Mascolo, N., Di Marzo, V. and Capasso, F. (2002) Endocannabinoids as physiological regulators of colonic propulsion in mice. Gastroenterology, 123, 227-234.
81. Piomelli, D., Beltramo, M., Glasnapp, S., Lin, S.Y., Goutopoulos, A., Xie, X.Q. and Makriyannis, A. (1999) Structural determinants for recognition and translocation by the anandamide transporter. Proc. Natl. Acad. Sci. USA, 96, 5802-5807.
82. Porter, A.C., Sauer, J.M., Knierman, M.D., Becker, G.W., Berna, M.J., Bao, J., Nomikos, G.G., Carter, P., Bymaster, F.P., Leese, A.B. and Felder, C.C. (2002) Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J. Pharmacol. Exp. Ther., 301, 1020-1024.
83. Rodriguez de Fonseca, F., Navarro, M., Gomez, R., Escuredo, L., Nava, F., Fu, J., Murillo-Rodriguez, E., Giuffrida, A., LoVerme, J., Gaetani, S., Kathuria, S., Gall, C. and Piomelli, D. (2001) An anorexic lipid mediator regulated by feeding. Nature, 414, 209-212.
84. Ross, R.A., Craib, S.J,, Stevenson, L.A., Pertwee, R.G., Henderson, A., Toole, J. and Ellington, H.C. (2002) Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide. J. Pharmacol. Exp. Ther., 301, 900-907.
85. Shim, Y.H., Lin, C.H. and Strickland, K.P. (1989) The purification and properties of monoacylglycerol kinase from bovine brain. Biochem. Cell Biol., 67, 233-241.
86. Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A. and Waku, K. (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun., 215, 89-97.
87. Thomas, E.A., Cravatt, B.F., Danielson, P.E., Gilula, N.B. and Sutcliffe, J.G. (1997) Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system. J. Neurosci. Res., 50, 1047-1052.
88. Ueda, N., Yamamoto, K., Yamamoto, S., Tokunaga, T., Shirakawa, E., Shinkai, H., Ogawa, M., Sato, T., Kudo, I., Inoue, K., Takizawa, H., Nagano, T., Hirobe, M., Matsuki, N. and Saito, H. (1995) Lipoxygenase-catalyzed oxygenation of arachidonylethanol-amide, a cannabinoid receptor agonist. Biochim. Biophys. Acta, 1254, 127-134.
89. Ueda, N., Yamanaka, K., Terasawa, Y. and Yamamoto, S. (1999) An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors. FEBS Lett., 454, 267-270.
90. Ueda, N., Yamanaka, K. and Yamamoto, S. (2001) Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance. J. Biol. Chem., 276, 35552-35557.
91. van der Stelt, M., van Kuik, J.A., Bari, M., van Zadelhoff, G., Leeflang, B.R., Veldink, G.A., Finazzi-Agro, A., Vliegenthart, J.F. and Maccarrone, M. (2002) Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. J. Med. Chem., 45, 3709-3720.
92. van Zadelhoff, G., Veldink, G.A. and Vliegenthart, J.F. (1998) With anandamide as substrate plant 5-lipoxygenases behave like 11-lipoxygenases. Biochem. Biophys. Res. Commun., 248, 33-38.
93. Veldhuis, W., Van der Stelt, M., Wadman, M., Zadelhoff, G., Maccarrone, M., Fezza, F., Veldink, G., Vliegenthart, J., Bar, P., Nicolay, K. and, Di Marzo, V. (2003) Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases. J. Neurosci., 23, 4127-4133.
94. Watanabe, K., Kayano, Y., Matsunaga, T., Yamamoto, I. and Yoshimura, H. (1996) Inhibition of anandamide amidase activity in mouse brain microsomes by cannabinoids. Biol. Pharm. Bull., 19, 1109-1111.
95. Wilson, R.I. and Nicoll, R.A. (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature, 410, 588-592.
96. Woodward, D.F., Krauss, A.H., Chen, J., Lai, R.K., Spada, C.S., Burk, R.M., Andrews, S.W., Shi, L., Liang, Y., Kedzie, K.M., Chen, R., Gil, D.W., Kharlamb, A., Archeampong, A., Ling, J., Madhu, C., Ni, J., Rix, P., Usansky, J., Usansky, H., Weber, A., Welty, D., Yang, W., Tang-Liu, D.D., Garst, M.E., Brar, B., Wheeler, L.A. and Kaplan, L.J. (2001) The pharmacology of bimatoprost (Lumigan). Surv. Ophthalmol., 45 Suppl. 4, S337-345.
97. Woodward, D.F., Krauss, A.H., Chen, J., Liang, Y., Li, C., Protzman, C.E., Bogardus, A., Chen, R., Kedzie, K.M., Krauss, H.A., Gil, D.W., Kharlamb, A., Wheeler, L.A., Babusis, D., Welty, D., Tang-Liu, D.D., Cherukury, M., Andrews, S.W., Burk, R.M. and Garst, M.E. (2003) Pharmacological Characterization of a Novel Anti-Glaucoma Agent, Bimatoprost (AGN 192024). J. Pharmacol. Exp. Ther., 24, 24.
98. Yu, M., Ives, D. and Ramesha, C.S. (1997) Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2. J. Biol. Chem., 272, 21181-21186.
99. Zygmunt, P.M., Chuang, H., Movahed, P., Julius, D. and Hogestatt, E.D. (2000) The anandamide transport inhibitor AM404 activates vanilloid receptors. Eur. J. Pharmacol., 396, 39-42.
100. Zygmunt, P.M., Petersson, J., Andersson, D.A., Chuang, H., Sorgard, M., Di Marzo, V., Julius, D. and Hogestatt, E.D. (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 400, 452-457.